IDR 575.0
(0.88%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 31.69 IDR | -13.93% |
2022 | 36.82 IDR | -12.91% |
2021 | 42.28 IDR | 35.77% |
2020 | 31.14 IDR | 15.63% |
2019 | 26.93 IDR | 21.69% |
2018 | 22.13 IDR | 24.26% |
2017 | 17.81 IDR | 10.42% |
2016 | 16.13 IDR | 10.94% |
2015 | 14.54 IDR | 5.29% |
2014 | 13.81 IDR | 2.83% |
2013 | 13.43 IDR | 4.76% |
2012 | 12.82 IDR | 13.96% |
2011 | 11.25 IDR | 43.31% |
2010 | 7.85 IDR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | 5.65 IDR | -22.28% |
2024 Q1 | 13.02 IDR | 7.25% |
2024 Q2 | 7.27 IDR | -44.16% |
2023 FY | - IDR | -13.93% |
2023 Q1 | 10.01 IDR | -21.86% |
2023 Q2 | 4.93 IDR | -50.75% |
2023 Q4 | 12.14 IDR | 162.77% |
2023 Q3 | 4.62 IDR | -6.29% |
2022 Q3 | 9.16 IDR | 82.47% |
2022 Q1 | 9.83 IDR | -25.42% |
2022 FY | - IDR | -12.91% |
2022 Q4 | 12.81 IDR | 39.85% |
2022 Q2 | 5.02 IDR | -48.93% |
2021 Q4 | 13.18 IDR | 8.75% |
2021 Q1 | 9.04 IDR | -7.57% |
2021 Q2 | 7.77 IDR | -14.05% |
2021 Q3 | 12.12 IDR | 55.98% |
2021 FY | - IDR | 35.77% |
2020 Q1 | 7.72 IDR | 1.05% |
2020 Q3 | 7.57 IDR | 24.51% |
2020 Q2 | 6.08 IDR | -21.24% |
2020 FY | - IDR | 15.63% |
2020 Q4 | 9.78 IDR | 29.19% |
2019 Q1 | 6.96 IDR | 13.54% |
2019 Q4 | 7.64 IDR | 12.19% |
2019 Q3 | 6.81 IDR | 23.59% |
2019 Q2 | 5.51 IDR | -20.83% |
2019 FY | - IDR | 21.69% |
2018 Q3 | 6.28 IDR | 53.55% |
2018 FY | - IDR | 24.26% |
2018 Q4 | 6.13 IDR | -2.39% |
2018 Q2 | 4.09 IDR | -27.48% |
2018 Q1 | 5.64 IDR | 10.37% |
2017 Q2 | 3.91 IDR | -8.0% |
2017 Q4 | 5.11 IDR | 13.05% |
2017 FY | - IDR | 10.42% |
2017 Q1 | 4.25 IDR | -0.93% |
2017 Q3 | 4.52 IDR | 15.6% |
2016 Q3 | 2.89 IDR | -39.29% |
2016 Q4 | 4.29 IDR | 48.44% |
2016 Q2 | 4.76 IDR | 11.48% |
2016 FY | - IDR | 10.94% |
2016 Q1 | 4.27 IDR | 12.37% |
2015 Q1 | 3.92 IDR | 17.72% |
2015 Q3 | 2.72 IDR | -35.85% |
2015 Q2 | 4.24 IDR | 8.16% |
2015 FY | - IDR | 5.29% |
2015 Q4 | 3.80 IDR | 39.71% |
2014 Q1 | 3.84 IDR | 12.61% |
2014 Q3 | -0.36 IDR | -105.19% |
2014 Q2 | 6.93 IDR | 80.47% |
2014 Q4 | 3.33 IDR | 1025.0% |
2014 FY | - IDR | 2.83% |
2013 Q4 | 3.41 IDR | -19.76% |
2013 FY | - IDR | 4.76% |
2013 Q2 | 3.17 IDR | 22.39% |
2013 Q3 | 4.25 IDR | 34.07% |
2013 Q1 | 2.59 IDR | 0.0% |
2012 FY | - IDR | 13.96% |
2011 FY | - IDR | 43.31% |
2010 FY | - IDR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 130.66 IDR | 75.746% |
PT Merck Tbk | 397.86 IDR | 92.035% |
PT Phapros, Tbk | 7.09 IDR | -346.968% |
PT Pyridam Farma Tbk | -34.20 IDR | 192.661% |
PT Tempo Scan Pacific Tbk | 261.08 IDR | 87.862% |